| Original language | English (US) |
|---|---|
| Pages (from-to) | 203 |
| Number of pages | 1 |
| Journal | Urology |
| Volume | 62 |
| Issue number | 2 |
| DOIs | |
| State | Published - Aug 1 2003 |
ASJC Scopus subject areas
- Urology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Urology, Vol. 62, No. 2, 01.08.2003, p. 203.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Letter from the editor
AU - Partin, Alan W.
N1 - Funding Information: We would like to take this opportunity to congratulate the winners of the 2002 AstraZeneca-sponsored Writing Competition for Residents and Fellows whose papers were published in UROLOGY. In 2002, more than 100 of the manuscripts published were first-authored by residents or fellows in Urology. Special thanks goes to Dr. Ralph Clayman for selecting the ten best papers. The Section and Associate Editors all voted for the top three papers. A $6000 award sponsored by AstraZeneca was divided among the top three award winners. First prize was awarded to Lorenz Höltl, M.D. of the University of Innsbruck for the manuscript entitled “Primary Lymphatic Metastatic Spread in Testicular Cancer Occurs Ventral to the Lumbar Vessels” (UROLOGY 59 : 114–118, 2002). Second prize was awarded to Atreya Dash, M.D. of the University of Michigan for the manuscript entitled “Prostate Cancer Involving the Bladder Neck: Recurrence-Free Survival and Implications for AJCC Staging Modification” (UROLOGY 60 : 276–280, 2002). Third prize was awarded to René Raaijmakers of Erasmus University for the manuscript entitled “Complication Rates and Risk Factors of 5802 Transrectal Ultrasound-Guided Sextant Biopsies of the Prostate Within a Population-Based Screening Program” (UROLOGY 60 : 826–830, 2002). We again are excited to announce that AstraZeneca, sponsor of this essay contest, has announced their continued support of the awards for 2003–2004 and we urge residents/fellows to submit manuscripts for this contest. The Editorial Board joins me in congratulating these young investigators and in thanking AstraZeneca for their continued support of The Gold Journal. Copyright: Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003/8/1
Y1 - 2003/8/1
UR - http://www.scopus.com/inward/record.url?scp=0043125569&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0043125569&partnerID=8YFLogxK
U2 - 10.1016/S0090-4295(03)00574-0
DO - 10.1016/S0090-4295(03)00574-0
M3 - Editorial
AN - SCOPUS:0043125569
SN - 0090-4295
VL - 62
SP - 203
JO - Urology
JF - Urology
IS - 2
ER -